Migraine drug with less side effects

Scientists 've come up with a revolutionary new drug that could help thousands of migraine sufferers who not respond to existing treatments.
A recent research analysis has revealed that as many as 33% of migraine sufferers lie in this category as do not respond to the best current therapy available, a class of drugs called triptans.

The study has posted that the drug telcagepant shows positive results in many people, whose headache pain is not cured or relieved using triptans, which are revealed to be the most effective currently available drugs for migraine treatments.

Clinical trials are revealed to be reviewed by Professor Lars Edvinsson, of University Hospital in Lund, Sweden, & Dr. Mattias Linde, of the Norwegian University of Science and Technology in Trondheim.

It is revealed that triptans cause the blood vessels to constrict, thereby making it inappropriate for use in people with heart disease or angina, history of stroke, uncontrolled high blood pressure, or pregnant women.Unlike, triptans, the new drug called telcagepant, could be recommended to the sufferers.The new migraine drug, Telcagepant inhibits the calcitonin-gene-related peptide (CGRP) receptor.

Amidst the new drug extending promises, doubts are obviously there in relation to its safety.